Stacey Rock
Nurse Practitioner · Lynchburg, VANPI 1578180162
Payments from drug & device makers
Across 304 payments — averaging $15.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$1K
- Johnson & Johnson$385
- AstraZeneca$358
- Lilly USA, LLC$286
- Pfizer$282
- plus $1K from 19 others
What the payments were for
- Food & beverage$4,673100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 89 | $1,194 |
| AbbVie | 89 | $1,129 |
| Johnson & Johnson | 12 | $385 |
| AstraZeneca | 21 | $358 |
| Lilly USA, LLC | 15 | $286 |
| Pfizer | 20 | $282 |
| Amgen | 9 | $135 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $121 |
| Sanofi-aventis U.S. LLC | 6 | $111 |
| Merck | 5 | $88 |
| Biohaven Pharmaceuticals, Inc. | 3 | $85 |
| Astellas Pharma US Inc | 4 | $78 |
| GSK | 4 | $65 |
| Teva Pharmaceuticals USA, Inc. | 3 | $60 |
| Bayer | 3 | $59 |
| Idorsia Pharmaceuticals US Inc | 3 | $44 |
| Amarin Pharma, Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Esperion Therapeutics, Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Acella Pharmaceuticals, LLC | 1 | $14 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$244
How this compares
$4,673 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 18 | $16,259 |
| MounjaroTirzepatide | 13 | $14,375 |
| EliquisApixaban | 12 | $9,114 |
| LinzessLinaclotide | 14 | $8,913 |
| Levothyroxine Sodium | 79 | $639 |
| Hydroxyzine Hcl | 15 | $472 |
| Atorvastatin Calcium | 61 | $439 |
| Lisinopril | 67 | $394 |
| Omeprazole | 31 | $358 |
| Rosuvastatin Calcium | 38 | $320 |
| Finasteride | 16 | $297 |
| Losartan Potassium | 26 | $281 |
| Bupropion XlBupropion Hcl | 14 | $268 |
| Pantoprazole Sodium | 17 | $254 |
| Metoprolol Succinate | 18 | $248 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $286 | $14,37513 claims |
| PfizerEliquis | $282 | $9,11412 claims |
| AbbVieLinzess | $1,129 | $8,91314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Lynchburg
- Morgan McDowellLynchburg$16K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
- Rachel AndersonCharlottesville$90K
- Megan FrancisArlington$81K
- Elizabeth WilletteNorfolk$58K
- Lacey LyleSuffolk$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.